H pylori seropositivity and cytokine gene polymorphisms

World Journal of Gastroenterology

Volumn 13, Issue 33, 2007, Pages 4445-4451

  Saijo, Yasuaki ^a   Yoshioka, Eiji ^b   Fukui, Tomonori ^b   Kawaharada, Mariko ^b   Sata, Fumihiro ^b   Sato, Hirokazu ^c   Kishi, Reiko ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JR Sapporo Hospital   (Japan)

Author keywords

Cytokines; H pylori seropositivity; Polymorphisms

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRINKING BEHAVIOR; EMPLOYEE; ENZYME ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; OCCUPATIONAL HEALTH; REFERENCE VALUE; RISK ASSESSMENT; SMOKING;

EID: 34548678422     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i33.4445     Document Type: Article

References (45)

1. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993; 34: 1672-1676
2. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-766
3. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490
4. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, Kishi R. Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects. Hypertens Res 2005; 28: 283-292
5. Franceachi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P, Roccarina D, Nista EC, Cazzato AI, Lupascu A, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis 2005; 37: 301-308
6. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 2005; 100: 1265-1270
7. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002; 16: 328-333
8. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-429
9. Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and turnout necrosis factor-alpha. J Gastroenterol Hepatol 1997; 12: 473-480
10. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 5964-5971
11. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998; 54: 139-150
12. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227-234
13. Saperas E, Tache Y. Central interleukin-1 beta-induced inhibition of acid secretion in rats: specificity of action. Life Sci 1993; 52: 785-792
14. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-1477
15. Lindholm C, Quiding-Jarbrink M, Lonroth H, Svennerholm AM. Induction of chemokine and cytokine responses by Helicobacter pyiori in human stomach explants. Scand J Gastroenterol 2001; 36: 1022-1029
16. Sutton P, Kolesnikow T, Danon S, Wilson J, Lee A. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun 2000; 68: 4802-4804
17. Katsuda N, Hamajima N, Tamakoshi A, Wakai K, Matsuo K, Saito T, Tajima K, Tominaga S. Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin-lB C-31T in Japanese health checkup examinees. Jpn J Clin Oncol 2003; 33: 192-197
18. Katsuda N, Hamajima N, Matsuo K, Saito T, Ito LS, Inoue M, Takezaki T, Tajima K, Tominaga S. Association between the interleukin 1B (C-31T) polymorphism and Helicobacter pylori infection in health checkup examinees. Nippon Koshu Eisei Zasshi 2001; 48: 604-612
19. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, Greco E, Gallo N, Rugge M, Di Mario F, Plebani M. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29: 141-152
20. Tseng FC, Brown EE, Maiese EM, Yeager M, Welch R, Gold BD, Owens M, Cranston B, Hanchard B, El-Omar E, Hisada M. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 2006; 11: 425-430
21. Hamajima N, Shibata A, Katsuda N, Matsuo K, Ito H, Saito T, Tajima K, Tominaga S. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer 2003; 6: 230-236
22. Atsuta Y, Ito LS, Oba-Shinjo SM, Uno M, Shinjo SK, Marie SK, Goto Y, Hamajima N. Associations of TNF-A-1031TF and -857TT genotypes with Helicobacter pylori seropositivity and gastric atrophy among Japanese Brazilians. Int J Clin Oncol 2006; 11: 140-145
23. Ogihara A, Kikuchi S, Hasegawa A, Kurosawa M, Miki K, Kaneko E, Mizukoshi H. Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol 2000; 15: 271-276
24. Brenner H, Berg G, Lappus N, Kliebsch U, Bode G, Boeing H. Alcohol consumption and Helicobacter pylori infection: results from the German National Health and Nutrition Survey. Epidemiology 1999; 10: 214-218
25. Gikas A, Triantafillidis JK, Apostolidis N, Mallas E, Peros G, Androulakis G. Relationship of smoking and coffee and alcohol consumption with seroconversion to Helicobacter pylori: a longitudinal study in hospital workers. J Gastroenterol Hepatol 2004; 19: 927-933
26. Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ 1997; 315: 1489-1492
27. Hamajima N, Matsuo K, Saito T, Tajima K, Okuma K, Yamao K, Tominaga S. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001; 92: 383-389
28. Uno M, Hamajima N, Ito LS, Oba SM, Marie SK, Shinjo SK, Onda H, Saito T, Takezaki T, Tajima K, Tominaga S. Helicobacter pylori seropositivity and IL-1B C-31T polymorphism among Japanese Brazilians. Int J Mol Med 2002; 10: 321-326
29. Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F. A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med 2002; 41: 780-783
30. Sata F, Yamada H, Suzuki K, Saijo Y, Yamada T, Minakami H, Kishi R. Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction. Pharmacogenet Genomics 2006; 16: 775-781
31. Suzuki K, Sata F, Yamada H, Saijo Y, Tsuruga N, Minakami H, Kishi R. Pregnancy-associated plasma protein-A polymorphism and the risk of recurrent pregnancy loss. J Reprod Immunol 2006; 70: 99-108
32. Barrett JC, Pry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265
33. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331-341
34. Van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, Kwiatkowski D. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002; 11: 1281-1289
35. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K. A polymorphism of the 5′ flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000; 52: 759-764
36. Higuchi T, Sell N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-612
37. Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX. Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock 2006; 26: 25-30
38. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB. Correlation. of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004; 50: 1976-1983
39. Saljo Y, Sata F, Yamada H, Kondo T, Kato EH, Kishi R. Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss in Japanese women. Fertil Steril 2004; 81: 374-378
40. Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, Lee JS, Chae DW. The -174 G to C polymorphism of interleukin-6 gene is very rare in koreans. Cytokine 2002; 19: 52-54
41. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M. A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001; 46: 267-272
42. Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T. Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 2002; 19: 1000-1005
43. Ortlepp JR, Metrikat J, Vesper K, Mevissen V, Schmitz F, Albrecht M, Maya-Pelzer P, Hanrath P, Weber C, Zerres K, Hoffmann R. The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. J Mol Med 2003; 81: 578-584
44. Hamajima N, Katsuda N, Matsuo K, Saito T, Hirose K, Inoue M, Zaki TT, Tajima K, Tominaga S. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8-251TT and IL-10-819TT genotypes. Helicobacter 2003; 8: 105-110
45. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201